Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
28.13
+0.71 (2.59%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Avalyn Pharma Employees
Avalyn Pharma had 55 employees as of June 30, 2026. The number of employees increased by 5 or 10.00% since the number was reported on December 31, 2025.
Employees
55
Change
5
Growth
10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,878,436
Market Cap
1.25B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 55 | 5 | 10.00% |
| Dec 31, 2025 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| Replimune Group | 465 |
| Omeros | 175 |
| ORIC Pharmaceuticals | 111 |
| Bicara Therapeutics | 103 |
| Nanobiotix | 100 |
| Savara | 70 |
| Damora Therapeutics | 7 |
AVLN News
- 2 days ago - Avalyn Pharma initiated with an Outperform at Raymond James - TheFly
- 13 days ago - Avalyn Pharma announces published results from Phase 1 trials of AP02 - TheFly
- 13 days ago - Avalyn Publishes Phase 1 Data Highlighting AP02's Lung-Targeted Delivery and Encouraging Safety Profile - GlobeNewsWire
- 18 days ago - Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors - GlobeNewsWire
- 20 days ago - Avalyn Pharma Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 26 days ago - Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 26 days ago - Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis - GlobeNewsWire
- 4 weeks ago - Avalyn Pharma Slides: Corporate presentation - Filings